tiprankstipranks
Carmell Therapeutics (CTCX)
NASDAQ:CTCX
US Market

Carmell Therapeutics (CTCX) Financial Statements

Compare
61 Followers

Carmell Therapeutics Financial Overview

Carmell Therapeutics's market cap is currently $13.60M. The company's EPS TTM is $-0.56; its P/E ratio is ―; Carmell Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ -124.79K$ -242.56K$ 0.00
Operating Income$ -5.22M$ -5.51M$ -1.94M
EBITDA$ -15.19M$ -5.25M$ -1.66M
Net Income$ -15.45M$ -9.05M$ -6.48M
Balance Sheet
Cash & Short-Term Investments$ 2.91M$ 128.15K$ 12.36K
Total Assets$ 63.95M$ 1.75M$ 1.56M
Total Debt$ 2.14M$ 3.74M$ 9.69M
Net Debt$ -776.01K$ 3.61M$ 9.67M
Total Liabilities$ 39.20M$ 39.54M$ 31.13M
Stockholders' Equity$ 24.75M$ -37.79M$ -29.58M
Cash Flow
Free Cash Flow$ -8.38M$ -3.44M$ -1.18M
Operating Cash Flow$ -8.35M$ -3.43M$ -1.18M
Investing Cash Flow$ -30.47K$ -7.16K$ -7.27K
Financing Cash Flow$ 11.16M$ 3.55M$ 1.20M
Currency in USD

Carmell Therapeutics Earnings and Revenue History

Carmell Therapeutics Debt to Assets

Carmell Therapeutics Cash Flow

Carmell Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis